Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property ; volume:14 ; pages:911-918
Beilstein journal of organic chemistry ; 14, 911-918
- Classification
-
Chemie
- DOI
-
10.3762/bjoc.14.78
- URN
-
urn:nbn:de:101:1-2018091309323164463893
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Other Objects (12)
Development of peptide-drug conjugates targeting mitochondria
Selectin-Targeting Peptide–Glycosaminoglycan Conjugates Modulate Neutrophil–Endothelial Interactions
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances
About the preparation of peptide conjugates
Targeting DNGR‐1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
Chlorofusin Cyclic Peptide Synthesis
Acridine–Peptide Conjugates by Solid-Phase Synthesis
Peptide-drug conjugates for advanced targeted cancer therapy
Cleavable Peptide-Triterpene Conjugates for Improved Gene Delivery
Solid-phase synthesis of peptide metal complex conjugates
Multivalent Peptide–Nanoparticle Conjugates for Influenza‐Virus Inhibition
Development of peptide-drug conjugates targeting mitochondria
Selectin-Targeting Peptide–Glycosaminoglycan Conjugates Modulate Neutrophil–Endothelial Interactions
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances
About the preparation of peptide conjugates
Targeting DNGR‐1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
Chlorofusin Cyclic Peptide Synthesis
Acridine–Peptide Conjugates by Solid-Phase Synthesis
Peptide-drug conjugates for advanced targeted cancer therapy
Cleavable Peptide-Triterpene Conjugates for Improved Gene Delivery
Solid-phase synthesis of peptide metal complex conjugates
Multivalent Peptide–Nanoparticle Conjugates for Influenza‐Virus Inhibition
Development of peptide-drug conjugates targeting mitochondria
Selectin-Targeting Peptide–Glycosaminoglycan Conjugates Modulate Neutrophil–Endothelial Interactions
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances
About the preparation of peptide conjugates
Targeting DNGR‐1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
Chlorofusin Cyclic Peptide Synthesis
Acridine–Peptide Conjugates by Solid-Phase Synthesis
Peptide-drug conjugates for advanced targeted cancer therapy
Cleavable Peptide-Triterpene Conjugates for Improved Gene Delivery
Solid-phase synthesis of peptide metal complex conjugates